Please provide your email address to receive an email when new articles are posted on . A recent advancement in minimally invasive spine surgery, unilateral biportal endoscopy integrates the ...

Editor’s Note: This profile is part of New Times’ People to Watch issue, spotlighting figures we expect to make a big impact in Miami in 2026. If there is a heroic endeavor to face in 2026, it’s ...

Midline officially opened its doors Friday night in Wynwood, and from the moment the night began, it was clear the venue was stepping into Miami’s live music ecosystem with confidence. By around 8 p.m ...

A massive new community is coming to Harris County, and it's planting roots right between Houston and Galveston. Brookfield Residential and CDC Houston have earmarked 1,066 acres in the booming ...

HOUSTON — Midline, a 1,000-acre community behind Baybrook Mall in southeast Houston, has a lineup of homebuilders for its first phase. Highland Homes, Perry Homes and Toll Brothers along with ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A new master-planned community ...

Modeyso is the first FDA-approved treatment for recurrent H3 K27M-mutant diffuse midline glioma, offering a new option for patients with limited choices. Phase II trials showed a 22% objective ...

What Is Modeyso, and Why Does It Matter? Modeyso (dordaviprone) is a new oral medicine that treats a rare and aggressive brain tumor, called diffuse midline glioma (DMG), that has a tumor mutation ...

Modeyso is the first FDA-approved systemic therapy for H3 K27M-mutant diffuse midline glioma, targeting both adult and pediatric patients. Clinical trials demonstrated a 22% overall response rate with ...

Dordaviprone is the first FDA-approved therapy for recurrent H3 K27M-mutant diffuse midline glioma, targeting an ultra-rare brain tumor in children and young adults. The approval was based on a 22% ...

The FDA granted accelerated approval to dordaviprone (Modeyso) as the first systemic therapy for adults and children with diffuse midline glioma harboring H3 K27M mutations. Labeling stipulates use in ...

Guidelines recommend against use of midline catheters for vancomycin-based outpatient parenteral antimicrobial therapy (OPAT), but evidence supporting the guidance is limited. This retrospective study ...